By Dietrich Knauth and Nate Raymond (Reuters) -Teva Pharmaceutical Industries on Tuesday announced a $4.25 billion proposed nationwide settlement that could resolve thousands of lawsuits over the drugmaker’s alleged role in the U.S. opioid epidemic. The proposal calls for Teva to pay up to $3.05 billion in cash over 13 years and provide $1.2 billion worth of the opioid overdose reversal drug naloxone. Israel-based Teva also will pay approximately $100 million to Native American tribes and pay attorneys fees incurred by the states, local governments and tribes. Teva’s proposed settlement would …